Concepts (219)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
---|
Pulmonary Fibrosis | 6 | 2024 | 175 | 3.140 |
Why?
|
Syndecan-2 | 5 | 2022 | 15 | 2.440 |
Why?
|
Heme Oxygenase-1 | 9 | 2014 | 57 | 1.920 |
Why?
|
Carbon Monoxide | 5 | 2017 | 67 | 1.620 |
Why?
|
Sepsis | 9 | 2021 | 686 | 1.550 |
Why?
|
Fibroblasts | 7 | 2024 | 1654 | 1.440 |
Why?
|
Lung Injury | 2 | 2022 | 145 | 1.420 |
Why?
|
HMGB1 Protein | 7 | 2013 | 42 | 1.390 |
Why?
|
Nitric Oxide Synthase Type II | 8 | 2013 | 262 | 1.370 |
Why?
|
Lipopolysaccharides | 8 | 2013 | 589 | 1.360 |
Why?
|
Cyclooxygenase 2 | 5 | 2010 | 495 | 1.190 |
Why?
|
Tetrahydroisoquinolines | 6 | 2014 | 24 | 1.050 |
Why?
|
Macrophages | 9 | 2021 | 1350 | 1.020 |
Why?
|
Idiopathic Pulmonary Fibrosis | 3 | 2023 | 172 | 1.020 |
Why?
|
p38 Mitogen-Activated Protein Kinases | 2 | 2024 | 344 | 0.940 |
Why?
|
Anti-Inflammatory Agents | 4 | 2013 | 451 | 0.880 |
Why?
|
Phosphatidylinositol 3-Kinases | 8 | 2022 | 1710 | 0.840 |
Why?
|
Radiation Injuries | 2 | 2022 | 1471 | 0.820 |
Why?
|
Lung | 8 | 2024 | 3298 | 0.800 |
Why?
|
Fibrosis | 1 | 2024 | 733 | 0.750 |
Why?
|
Bleomycin | 4 | 2024 | 482 | 0.730 |
Why?
|
Organometallic Compounds | 3 | 2010 | 209 | 0.730 |
Why?
|
Arthritis, Rheumatoid | 2 | 2023 | 496 | 0.700 |
Why?
|
Vascular Cell Adhesion Molecule-1 | 2 | 2010 | 123 | 0.670 |
Why?
|
Intercellular Adhesion Molecule-1 | 2 | 2010 | 227 | 0.660 |
Why?
|
Anthocyanins | 2 | 2008 | 5 | 0.650 |
Why?
|
Proto-Oncogene Proteins c-akt | 6 | 2022 | 2069 | 0.640 |
Why?
|
Mesenchymal Stem Cell Transplantation | 3 | 2021 | 205 | 0.620 |
Why?
|
PTEN Phosphohydrolase | 3 | 2014 | 1012 | 0.550 |
Why?
|
Receptor-Like Protein Tyrosine Phosphatases, Class 3 | 3 | 2022 | 16 | 0.550 |
Why?
|
Phagocytosis | 4 | 2021 | 292 | 0.540 |
Why?
|
Ultraviolet Rays | 2 | 2008 | 588 | 0.540 |
Why?
|
Janus Kinase 2 | 3 | 2010 | 754 | 0.530 |
Why?
|
Gene Expression Regulation | 5 | 2022 | 4130 | 0.530 |
Why?
|
Mice | 28 | 2024 | 35600 | 0.530 |
Why?
|
Endotoxemia | 3 | 2011 | 72 | 0.520 |
Why?
|
Proto-Oncogene Proteins c-ets | 1 | 2014 | 98 | 0.460 |
Why?
|
Animals | 31 | 2024 | 61956 | 0.460 |
Why?
|
Membrane Proteins | 4 | 2014 | 2928 | 0.440 |
Why?
|
Interferon-beta | 2 | 2010 | 109 | 0.420 |
Why?
|
Nitric Oxide | 4 | 2011 | 658 | 0.420 |
Why?
|
Lipids | 1 | 2016 | 654 | 0.420 |
Why?
|
Kruppel-Like Transcription Factors | 1 | 2014 | 277 | 0.420 |
Why?
|
NF-kappa B | 5 | 2021 | 1563 | 0.420 |
Why?
|
Mice, Inbred BALB C | 7 | 2020 | 2454 | 0.410 |
Why?
|
Cell Line | 9 | 2014 | 5338 | 0.400 |
Why?
|
Citrullination | 2 | 2022 | 7 | 0.400 |
Why?
|
Cyperus | 1 | 2011 | 1 | 0.390 |
Why?
|
Seeds | 2 | 2008 | 44 | 0.390 |
Why?
|
Tumor Necrosis Factor-alpha | 4 | 2014 | 1584 | 0.390 |
Why?
|
Macrophages, Alveolar | 2 | 2020 | 71 | 0.380 |
Why?
|
Sesquiterpenes | 1 | 2011 | 70 | 0.380 |
Why?
|
GATA6 Transcription Factor | 1 | 2010 | 20 | 0.370 |
Why?
|
Myofibroblasts | 2 | 2024 | 97 | 0.360 |
Why?
|
Dinoprostone | 2 | 2008 | 219 | 0.360 |
Why?
|
STAT1 Transcription Factor | 2 | 2008 | 162 | 0.360 |
Why?
|
Nicotinic Agonists | 1 | 2011 | 120 | 0.340 |
Why?
|
Glycogen Synthase Kinase 3 | 1 | 2010 | 152 | 0.340 |
Why?
|
Inflammation | 3 | 2021 | 2518 | 0.340 |
Why?
|
Gene Expression Regulation, Enzymologic | 2 | 2009 | 694 | 0.340 |
Why?
|
Receptors, Nicotinic | 1 | 2011 | 205 | 0.340 |
Why?
|
Plant Extracts | 1 | 2011 | 221 | 0.330 |
Why?
|
Caspase Inhibitors | 1 | 2008 | 95 | 0.320 |
Why?
|
PPAR gamma | 1 | 2009 | 225 | 0.310 |
Why?
|
Nicotine | 1 | 2011 | 265 | 0.310 |
Why?
|
Macrophage Activation | 1 | 2008 | 151 | 0.300 |
Why?
|
Skin | 3 | 2024 | 1271 | 0.290 |
Why?
|
Metformin | 1 | 2011 | 393 | 0.280 |
Why?
|
Cell Adhesion | 1 | 2009 | 1028 | 0.270 |
Why?
|
Transfection | 4 | 2014 | 3117 | 0.260 |
Why?
|
Enzyme Activation | 2 | 2024 | 1810 | 0.240 |
Why?
|
Gene Silencing | 3 | 2021 | 827 | 0.240 |
Why?
|
Up-Regulation | 3 | 2019 | 2422 | 0.220 |
Why?
|
Endothelial Cells | 1 | 2009 | 1038 | 0.210 |
Why?
|
Autophagy | 2 | 2021 | 911 | 0.210 |
Why?
|
Scleroderma, Systemic | 1 | 2024 | 165 | 0.210 |
Why?
|
Transforming Growth Factor beta1 | 1 | 2024 | 294 | 0.210 |
Why?
|
Anti-Citrullinated Protein Antibodies | 1 | 2022 | 4 | 0.200 |
Why?
|
Sarcoidosis | 1 | 2023 | 113 | 0.200 |
Why?
|
Mice, Transgenic | 2 | 2022 | 4223 | 0.200 |
Why?
|
Signal Transduction | 8 | 2021 | 12103 | 0.190 |
Why?
|
Disease Models, Animal | 6 | 2021 | 7381 | 0.190 |
Why?
|
Elastic Tissue | 1 | 2021 | 35 | 0.190 |
Why?
|
Cells, Cultured | 6 | 2017 | 5694 | 0.190 |
Why?
|
Lung Diseases, Interstitial | 1 | 2023 | 216 | 0.190 |
Why?
|
Sp1 Transcription Factor | 1 | 2022 | 193 | 0.190 |
Why?
|
Primary Cell Culture | 1 | 2021 | 199 | 0.180 |
Why?
|
Mice, Knockout | 4 | 2021 | 5728 | 0.180 |
Why?
|
Palmitic Acid | 1 | 2019 | 43 | 0.170 |
Why?
|
Extracellular Matrix Proteins | 1 | 2021 | 293 | 0.170 |
Why?
|
RNA Interference | 4 | 2013 | 1388 | 0.170 |
Why?
|
Chemokine CXCL12 | 1 | 2020 | 131 | 0.170 |
Why?
|
Syntenins | 1 | 2019 | 5 | 0.170 |
Why?
|
Biological Specimen Banks | 1 | 2020 | 75 | 0.170 |
Why?
|
Extracellular Vesicles | 1 | 2021 | 134 | 0.160 |
Why?
|
Cryopreservation | 1 | 2020 | 151 | 0.160 |
Why?
|
A549 Cells | 1 | 2019 | 128 | 0.160 |
Why?
|
Mice, Hairless | 2 | 2008 | 57 | 0.160 |
Why?
|
In Vitro Techniques | 1 | 2021 | 1697 | 0.160 |
Why?
|
Transcription Factor RelA | 1 | 2019 | 184 | 0.160 |
Why?
|
Humans | 18 | 2024 | 270740 | 0.150 |
Why?
|
Cell Survival | 4 | 2020 | 3063 | 0.150 |
Why?
|
Protein Kinase C | 2 | 2011 | 407 | 0.150 |
Why?
|
Endoplasmic Reticulum Stress | 1 | 2019 | 203 | 0.150 |
Why?
|
Diet, High-Fat | 1 | 2019 | 247 | 0.150 |
Why?
|
Antibiotics, Antineoplastic | 1 | 2021 | 742 | 0.150 |
Why?
|
Matrix Metalloproteinase 9 | 1 | 2019 | 350 | 0.150 |
Why?
|
Keratinocytes | 2 | 2008 | 244 | 0.150 |
Why?
|
TOR Serine-Threonine Kinases | 2 | 2021 | 1563 | 0.150 |
Why?
|
rho-Associated Kinases | 1 | 2018 | 80 | 0.150 |
Why?
|
Neutrophils | 3 | 2021 | 873 | 0.140 |
Why?
|
Pyridines | 1 | 2024 | 1313 | 0.140 |
Why?
|
Autophagy-Related Proteins | 1 | 2017 | 55 | 0.140 |
Why?
|
Apoptosis | 3 | 2019 | 7757 | 0.140 |
Why?
|
Dose-Response Relationship, Drug | 5 | 2014 | 5056 | 0.140 |
Why?
|
Phosphorylation | 3 | 2010 | 4942 | 0.140 |
Why?
|
Blotting, Western | 2 | 2014 | 3584 | 0.140 |
Why?
|
Pyrimidines | 2 | 2024 | 3669 | 0.140 |
Why?
|
Thorax | 1 | 2018 | 229 | 0.140 |
Why?
|
Lung Neoplasms | 1 | 2019 | 12033 | 0.130 |
Why?
|
Cell Proliferation | 2 | 2019 | 7238 | 0.130 |
Why?
|
Peptide Fragments | 1 | 2021 | 1309 | 0.130 |
Why?
|
CD8-Positive T-Lymphocytes | 1 | 2023 | 1655 | 0.130 |
Why?
|
Recombinant Proteins | 1 | 2021 | 3028 | 0.130 |
Why?
|
NF-E2-Related Factor 2 | 3 | 2013 | 256 | 0.120 |
Why?
|
Mice, SCID | 1 | 2019 | 1826 | 0.120 |
Why?
|
Reactive Oxygen Species | 2 | 2011 | 1005 | 0.120 |
Why?
|
Enzyme Inhibitors | 3 | 2013 | 1942 | 0.110 |
Why?
|
Cell Nucleus | 1 | 2019 | 1712 | 0.110 |
Why?
|
Cell Differentiation | 1 | 2024 | 4116 | 0.110 |
Why?
|
Mutagenesis, Site-Directed | 1 | 2014 | 631 | 0.110 |
Why?
|
Chromatin Immunoprecipitation | 1 | 2014 | 507 | 0.110 |
Why?
|
Mice, Inbred C57BL | 3 | 2020 | 7100 | 0.110 |
Why?
|
Mammary Glands, Human | 1 | 2014 | 182 | 0.110 |
Why?
|
Protein-Arginine Deiminases | 2 | 2023 | 7 | 0.110 |
Why?
|
Dermatologic Agents | 1 | 2013 | 44 | 0.100 |
Why?
|
Cell Movement | 2 | 2018 | 2472 | 0.100 |
Why?
|
Transforming Growth Factor beta | 1 | 2018 | 1109 | 0.100 |
Why?
|
Wounds, Penetrating | 1 | 2013 | 157 | 0.100 |
Why?
|
Phenotype | 2 | 2021 | 6509 | 0.100 |
Why?
|
Escherichia coli Infections | 1 | 2014 | 272 | 0.100 |
Why?
|
Rhizome | 1 | 2011 | 8 | 0.100 |
Why?
|
AMP-Activated Protein Kinases | 2 | 2013 | 402 | 0.100 |
Why?
|
Plants, Medicinal | 1 | 2011 | 49 | 0.100 |
Why?
|
RNA, Small Interfering | 3 | 2014 | 2196 | 0.100 |
Why?
|
Mice, Inbred ICR | 1 | 2011 | 244 | 0.090 |
Why?
|
Peptidoglycan | 1 | 2010 | 20 | 0.090 |
Why?
|
alpha7 Nicotinic Acetylcholine Receptor | 1 | 2011 | 59 | 0.090 |
Why?
|
Poly I-C | 1 | 2010 | 31 | 0.090 |
Why?
|
Gene Expression Regulation, Neoplastic | 2 | 2019 | 9042 | 0.090 |
Why?
|
Neoplasm Invasiveness | 1 | 2019 | 4048 | 0.090 |
Why?
|
Cytokines | 2 | 2011 | 2825 | 0.090 |
Why?
|
Real-Time Polymerase Chain Reaction | 1 | 2014 | 1199 | 0.090 |
Why?
|
Peroxidase | 1 | 2011 | 133 | 0.090 |
Why?
|
NADPH Oxidases | 1 | 2011 | 146 | 0.090 |
Why?
|
Oxidative Stress | 1 | 2017 | 1149 | 0.090 |
Why?
|
Glycogen Synthase Kinase 3 beta | 1 | 2010 | 157 | 0.090 |
Why?
|
Mitochondria | 1 | 2017 | 1297 | 0.090 |
Why?
|
Glutathione | 1 | 2012 | 374 | 0.090 |
Why?
|
Toll-Like Receptors | 1 | 2010 | 170 | 0.090 |
Why?
|
Interleukin-1beta | 1 | 2011 | 294 | 0.080 |
Why?
|
Protoporphyrins | 1 | 2009 | 10 | 0.080 |
Why?
|
Hemin | 1 | 2009 | 29 | 0.080 |
Why?
|
Calcium Signaling | 1 | 2011 | 282 | 0.080 |
Why?
|
U937 Cells | 1 | 2009 | 178 | 0.080 |
Why?
|
Protein Processing, Post-Translational | 2 | 2023 | 809 | 0.080 |
Why?
|
Alkaloids | 1 | 2008 | 85 | 0.080 |
Why?
|
Active Transport, Cell Nucleus | 1 | 2009 | 318 | 0.080 |
Why?
|
Cell Line, Transformed | 1 | 2008 | 427 | 0.080 |
Why?
|
Wound Healing | 1 | 2013 | 749 | 0.080 |
Why?
|
Cyclooxygenase 2 Inhibitors | 1 | 2008 | 198 | 0.070 |
Why?
|
TYK2 Kinase | 1 | 2006 | 12 | 0.070 |
Why?
|
Paclitaxel | 1 | 2014 | 2101 | 0.070 |
Why?
|
Bacteremia | 1 | 2013 | 721 | 0.070 |
Why?
|
Cytoplasm | 1 | 2009 | 702 | 0.070 |
Why?
|
Vascular Endothelial Growth Factor A | 1 | 2013 | 1580 | 0.070 |
Why?
|
Time Factors | 2 | 2011 | 13006 | 0.070 |
Why?
|
Isoquinolines | 1 | 2006 | 125 | 0.070 |
Why?
|
Naphthalenes | 1 | 2006 | 84 | 0.070 |
Why?
|
Male | 8 | 2019 | 128315 | 0.070 |
Why?
|
Mitogen-Activated Protein Kinases | 1 | 2008 | 669 | 0.060 |
Why?
|
Monocytes | 1 | 2009 | 790 | 0.060 |
Why?
|
Aorta, Thoracic | 1 | 2009 | 534 | 0.060 |
Why?
|
Rats, Sprague-Dawley | 1 | 2009 | 2156 | 0.060 |
Why?
|
Immunoglobulin A | 1 | 2023 | 271 | 0.050 |
Why?
|
Immunoglobulin M | 1 | 2023 | 359 | 0.050 |
Why?
|
Pyrazoles | 1 | 2011 | 1546 | 0.050 |
Why?
|
Kaplan-Meier Estimate | 1 | 2011 | 6256 | 0.050 |
Why?
|
Survival Rate | 2 | 2013 | 12541 | 0.050 |
Why?
|
Paracrine Communication | 1 | 2021 | 128 | 0.050 |
Why?
|
Ubiquitination | 1 | 2023 | 579 | 0.050 |
Why?
|
Gene Expression | 1 | 2008 | 3640 | 0.040 |
Why?
|
Cell Polarity | 1 | 2021 | 212 | 0.040 |
Why?
|
Rats | 1 | 2009 | 6441 | 0.040 |
Why?
|
CD36 Antigens | 1 | 2019 | 50 | 0.040 |
Why?
|
Models, Biological | 1 | 2008 | 3194 | 0.040 |
Why?
|
Interferon-gamma | 1 | 2023 | 1179 | 0.040 |
Why?
|
Immunity | 1 | 2021 | 354 | 0.040 |
Why?
|
Calcium-Binding Proteins | 1 | 2021 | 545 | 0.040 |
Why?
|
Intracellular Space | 1 | 2017 | 78 | 0.040 |
Why?
|
Membrane Potential, Mitochondrial | 1 | 2017 | 126 | 0.030 |
Why?
|
Female | 3 | 2018 | 148940 | 0.030 |
Why?
|
Models, Theoretical | 1 | 2020 | 799 | 0.030 |
Why?
|
Proteins | 1 | 2023 | 2043 | 0.030 |
Why?
|
Gene Expression Regulation, Developmental | 1 | 2021 | 1503 | 0.030 |
Why?
|
Adenosine Triphosphate | 1 | 2017 | 584 | 0.030 |
Why?
|
bcl-X Protein | 1 | 2014 | 198 | 0.030 |
Why?
|
Proteomics | 1 | 2021 | 1427 | 0.030 |
Why?
|
Antioxidants | 1 | 2017 | 521 | 0.030 |
Why?
|
I-kappa B Kinase | 1 | 2014 | 248 | 0.030 |
Why?
|
Caspase 3 | 1 | 2014 | 474 | 0.030 |
Why?
|
Cecum | 1 | 2013 | 31 | 0.030 |
Why?
|
Epithelial Cells | 1 | 2019 | 1875 | 0.030 |
Why?
|
Antineoplastic Agents | 1 | 2014 | 14617 | 0.020 |
Why?
|
Random Allocation | 1 | 2013 | 741 | 0.020 |
Why?
|
Drug Synergism | 1 | 2014 | 1356 | 0.020 |
Why?
|
Bone Marrow Cells | 1 | 2013 | 968 | 0.020 |
Why?
|
Enzyme Induction | 1 | 2006 | 257 | 0.020 |
Why?
|
Cell Line, Tumor | 1 | 2014 | 14849 | 0.010 |
Why?
|